These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 823117)

  • 1. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.
    Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA
    Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity of cholera toxoid in humans.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of a purified antigenic cholera toxoid.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    Infect Immun; 1976 Jun; 13(6):1692-8. PubMed ID: 823107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.
    Rappaport RS; Bonde G; McCann T; Rubin BA; Tint H
    Infect Immun; 1974 Feb; 9(2):304-17. PubMed ID: 4205946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.
    Levine MM; Hughes TP; Young CR; O'Donnell S; Craig JP; Holley HP; Bergquist EJ
    Infect Immun; 1978 Jul; 21(1):158-62. PubMed ID: 101456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals].
    Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A toxoid prepared from cholera toxin by iodination.
    Heneine IF; Lahmann WM; Rocha OA
    Braz J Med Biol Res; 1992; 25(9):913-7. PubMed ID: 1342838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a purified cholera toxoid. I. Purification of toxin.
    Rappaport RS; Rubin BA; Tint H
    Infect Immun; 1974 Feb; 9(2):294-303. PubMed ID: 4205945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic immunity of experimental animals immunized with cholera vaccines].
    Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against experimental cholera by oral or parenteral immunization.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.
    Svennerholm AM; Holmgren J
    Infect Immun; 1976 Mar; 13(3):735-40. PubMed ID: 1270131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin.
    Cruce DD; Wachsmuth IK; Feeley JC
    Diagn Immunol; 1983; 1(2):87-9. PubMed ID: 6680095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvant effect of pertussis endotoxin protein in modulating the immune response to cholera toxoid in mice.
    Sultzer BM; Craig JP; Castagna R
    Dev Biol Stand; 1985; 61():225-32. PubMed ID: 2872108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.
    Mekalanos JJ; Collier RJ; Romig WR
    Infect Immun; 1977 Jun; 16(3):789-95. PubMed ID: 892899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.
    Pierce NF; Cray WC; Sircar BK
    Infect Immun; 1978 Jul; 21(1):185-93. PubMed ID: 711314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the immunogenic properties of cholerogen-anatoxin according to gel precipitation reactions and quantity of reducing sugars].
    Dzhaparidze MN; Martens LA; Egorova VD; Karaeva LT; Derteva II
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):48-51. PubMed ID: 808056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the heterogenetic antigens in vaccinal preparations of V. cholerae].
    Zhukov-Verezhnikov NN; Anisimov PI; Goncharova NS; Bochko GM; Karaseva ZN
    Biull Eksp Biol Med; 1976 Aug; 82(8):961-2. PubMed ID: 1088347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.